ABVD chemotherapy in the treatment of Hodgkin's disease
- 31 March 1982
- journal article
- clinical trial
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 9 (1), 21-35
- https://doi.org/10.1016/s0305-7372(82)80003-0
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky memorial lectureCancer, 1981
- Curative potential of combined modality therapy for advanced Hodgkin's diseaseCancer, 1980
- Curability of Advanced Hodgkin's Disease with ChemotherapyAnnals of Internal Medicine, 1980
- Prolonged Disease-Free Survival in Hodgkin's Disease with MOPP Reinduction After First RelapseAnnals of Internal Medicine, 1979
- Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV)Cancer, 1977
- COMBINATION THERAPY FOR ADVANCED RESISTANT HODGKIN'S DISEASEThe Lancet, 1975
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975
- Recent trends in the medical treatment of Hodgkin's diseaseEuropean Journal of Cancer (1965), 1975
- Combination chemotherapy of advanced Hodgkin's disease.A reviewCancer, 1974
- Combination Chemotherapy in the Treatment of Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1970